8-KItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Boston Scientific ($BSX) filed an 8‑K on Jan 15, 2026: Item 9.01 lists exhibits — a press release and…
Filed with the SEC on · Summarized by InvestorsBot
Boston Scientific ($BSX) filed an 8‑K on Jan 15, 2026: Item 9.01 lists exhibits — a press release and investor presentation — now on EDGAR. Investors should review exhibits for material updates. 📄📈 #SECfiling #BostonScientific #MedTech
Exhibits filed 1/15/2026: 99.1 Press Release, 99.2 Investor Presentation; 104 Cover Page Interactive XBRL (cover page tags embedded). Full exhibits available on EDGAR. 🔎📎 $BSX #SECfiling #investors
Form 8‑K signed Jan 15, 2026 by Susan Thompson, VP & Chief Corporate Counsel (Asst Secretary), certifying the filing. Item 9.01 contains exhibits only — no separate financial statements disclosed here. ✍️🕒 $BSX #BostonScientific #disclosure